Reply to: Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature

dc.contributor.authors	Solak, B; Solak, Y;
dc.date.accessioned	2020-02-27T08:26:32Z
dc.date.available	2020-02-27T08:26:32Z
dc.date.issued	2017
dc.identifier.citation	Solak, B; Solak, Y; (2017). Reply to: Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature. JOURNAL OF DERMATOLOGICAL TREATMENT, 28, 280-280
dc.identifier.issn	0954-6634
dc.identifier.uri	https://doi.org/10.1080/09546634.2016.1215404
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65831
dc.language	English
dc.publisher	TAYLOR & FRANCIS LTD
dc.subject	Dermatology
dc.title	Reply to: Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature
dc.type	Letter
dc.identifier.volume	28
dc.identifier.startpage	280
dc.identifier.endpage	280
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Dahili Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Solak, Berna
dc.relation.journal	JOURNAL OF DERMATOLOGICAL TREATMENT
dc.identifier.wos	WOS:000401454000018
dc.identifier.doi	10.1080/09546634.2016.1215404
dc.identifier.eissn	1471-1753
dc.contributor.author	Solak, Berna
dc.contributor.author	Yalcin Solak